BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 340586)

  • 21. Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin.
    Kawata M; Sizer K; Sekiya S; Parnes JR; Herzenberg LA
    Cancer Res; 1984 Sep; 44(9):4011-6. PubMed ID: 6204750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Separation and comparison of human TL-like antigens and HLA(A, B, C) antigens expressed on cultured T cells.
    Tokuyama H; Tanigaki N
    Immunogenetics; 1981; 13(1-2):147-65. PubMed ID: 6164635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.
    Baba T; Hanagiri T; Ichiki Y; Kuroda K; Shigematsu Y; Mizukami M; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
    Cancer Sci; 2007 Nov; 98(11):1795-802. PubMed ID: 17725806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cross-reaction between beta2-microglobulin and kappa-light chains.
    Gottlieb AB; Engelhard M; Kunkel HG; Tanigaki N; Pressman D
    J Immunol; 1977 Dec; 119(6):2001-4. PubMed ID: 72113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Properties of a surface antigen expressed on activated human thymus-derived lymphocytes.
    Udey MC; Jendrisak MD; Parker CW
    J Immunol; 1982 Apr; 128(4):1870-5. PubMed ID: 6801123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of HLA-A, -B, and -C and beta 2-microglobulin antigens in human choriocarcinoma cell lines.
    Trowsdale J; Travers P; Bodmer WF; Patillo RA
    J Exp Med; 1980 Aug; 152(2 Pt 2):11s-17s. PubMed ID: 6157763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
    Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
    J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunologic and molecular profiles of HLA antigens isolated from urine.
    Reisfeld RA; Pellegrino MA; Ferrone S
    J Immunol; 1977 Jan; 118(1):264-9. PubMed ID: 63518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of stable and unstable ("suppressed") Beta2-microglobulin-deficient clones from a lymphoid cell line.
    Pious D; Soderland C; Weagant S; Poulik D
    J Immunol; 1976 Feb; 116(2):570-2. PubMed ID: 55445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines.
    Travers PJ; Arklie JL; Trowsdale J; Patillo RA; Bodmer WF
    Natl Cancer Inst Monogr; 1982; 60():175-80. PubMed ID: 6181407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.
    Nomura T; Huang WC; Seo S; Zhau HE; Mimata H; Chung LW
    J Urol; 2007 Jul; 178(1):292-300. PubMed ID: 17499801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Beta2-microglobulin: structure and function of an immunoglobulin-homologue (author's transl)].
    Hütteroth TH; Cleve H
    Immun Infekt; 1976 Jun; 4(3):110-5. PubMed ID: 61164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MHC class I and class I-like gene product expression by malignant T cells: relationships between CD1a, HLA-ABC and beta 2-microglobulin.
    Jones RA; Scott CS; Katz FE; Child JA
    Clin Exp Immunol; 1988 Dec; 74(3):454-8. PubMed ID: 2466592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of immunoglobulin-cross-reactive molecules by neoplastic human T cells. I. Surface detection and isolation of molecules reactive with chicken anti-F(ab')2, anti-alpha and anti-mu antibodies.
    Haegert DG; Timm M
    Immunology; 1983 Nov; 50(3):447-59. PubMed ID: 6195097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.
    Romagnani C; Pietra G; Falco M; Millo E; Mazzarino P; Biassoni R; Moretta A; Moretta L; Mingari MC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11328-33. PubMed ID: 12167676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular expression or binding of desLys58-beta2 microglobulin is not dependent on the presence of the tri-molecular MHC class I complex.
    Wang M; Corlin DB; Heegaard NH; Claesson MH; Nissen MH
    Scand J Immunol; 2008 Feb; 67(2):105-12. PubMed ID: 18069937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid purification of detergent-solubilized HLA antigen by affinity chromatography employing anti-beta2-microglobulin serum.
    Robb RJ; Strominger JL
    J Biol Chem; 1976 Sep; 251(17):5427-8. PubMed ID: 60339
    [No Abstract]   [Full Text] [Related]  

  • 39. Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition.
    Kitamura H; Torigoe T; Asanuma H; Honma I; Sato N; Tsukamoto T
    J Urol; 2007 Aug; 178(2):692-6. PubMed ID: 17574613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of melanoma tumor antigen activity with beta2-microglobulin.
    Malley A; Burger DR; Vandenbark AA; Frikke M; Finke P; Begley D; Acott K; Black J; Vetto RM
    Cancer Res; 1979 Feb; 39(2 Pt 2):619-23. PubMed ID: 83915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.